Diagnosis And Risk Determination Of Diabetes Dealing With Diabetes
Abstract
Diabetes mellitus occurs due to insufficiency, absence and/or lack of insulin hormone that causes defects on carbohydrate, protein and fat metabolisms, and is an endocrinologic and metabolic disease characterized by chronic hyperglycemia. When it is not cured well and on time can cause to failures on whole systems. Hypertension, obesity and the presence of diabetes among family members are predisposant factors for the development of Type 2 Diabetes Mellitus. In this paper the importance, the determination of risk factors and current approaches to the diagnosis and classification of diabetes are reviewed.
References
- Bennet PH, Knowler WC. Definition, Diagnosis and Classification of Diabetes Mellitus and Glucose Homeostaisis. In “Joslin Diabetes Mellitus”. (eds) Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ. 14th ed, Philadelphia, Lippincott Williams &Wilkins, 2005; 331-339.
- Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD): Diabetes Mellitus Çalışma ve Eğitim Grupları 2009. Diabetes Mellitus ve Komplikasyonlarının Tanı Tedavi ve İzlem Klavuzu.4. Baskı. İstanbul, 2009.
- International Diabetes Federation: Diabetes Atlas, 4th Edition, 2009, http://www.diabetesatlas.org adresinden 08/08/2011 tarihinde erişilmiştir.
- American Diabetes Association: Standards of medical care in diabetes-2010. Diabetes Care, 2010;33(1):11-61.
- American Diabetes Association: Standards of medical care in diabetes-2011. Diabetes Care, 2011;34 (1):11-61.
- Olgun N, Eti Aslan F, Coşansu G, Çelik S. Diabetes mellitus. “Dahili ve Cerrahi Hastalıklarda Bakım” içinde. (ed) Karadakovan A, Aslan FE. Adana, Nobel Tıp Kitabevi, 2010;829-864.
- World Health Organization: Definition and Diagnosiss of Diabetes Mellitus and Intermedia Hyperglycemia. Report of WHO/IDF Consultation. Geneva, Switzerland, 2006.
- United Nations Resolution 61/225: World Diabetes Day http://www.idf.org/book/export/html/23155 adresinden 08/08/2011 tarihinde erişilmiştir.
- Unvin, N, Marlin, A. Diabetes action now: WHO and IDF working together to raise awareness worldwide. Diabetes Voice, 2004;49(2) 27–31.
- Biçer EK, Özyazar M, Çevik AB. Endokrinoloji, diyabet ve metabolizma servisine yatan diyabetik hastalarda komplikasyonlar ve mali yük, Diyabet Obezite ve Hipertansiyonda Hemşirelik Forumu, 2009;1(2):6-13.
- TC Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü, Türkiye Diyabet Önleme ve Kontrol Programı. Ankara 2011.
- Karşıdağ K, Malhan S. Türkiye’de diyabetin toplumsal yükü: Hastalık yönetimi ve maliyet açısından bir değerlendirme”, 47. Ulusal Diyabet Kongresi, 2011, Antalya, PS01, S.106.
- International Diabetes Federation. Diabetes Atlas. 3rd edition. International Diabetes Federation Publ, Brussels, 2006.
- Yılmaz T. Tip 1 diabetes mellitus. “Diabetes Mellitus“ içinde. (ed) İmamoğlu Ş, Ersoy C. 3. Baskı. İstanbul, Deomed Medikal Yayıncılık, 2009; 38-51.
- Kabalak T, Çetinkalp Ş. Tip 2 diabetes mellitus. “Diabetes Mellitus” içinde. (ed) İmamoğlu Ş, Ersoy C. 3. Baskı, İstanbul, Deomed Medikal Yayıncılık, 2009;54-72.
- Satman, I. Diabetes Mellitus Epidemiyolojisi. “Diabetes Mellitus“ içinde. (ed) İmamoğlu Ş, Ersoy C. 3. Baskı. İstanbul, Deomed Medikal Yayıncılık, 2009; 11-35.
- Gogas, D, Deyneli, O, Aydın H, Tarçın Ö. “Diabetes Mellitus 2009” içinde Diyabet ve Gebelik. (ed) İmamoğlu Ş, Ersoy C. 3. Baskı, İstanbul, Deomed Medikal Yayıncılık, 2009; 531-536.
- Bhattacharyya O.K, Estey EA, Cheng AY. Update on the Canadian Diabetes Association 2008 clinical practice guidelines. Can Fam Physician 2009;55: 39-43.
- Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Warren L, et al. ISPAD Clinical Practice Consensus Guidelines. Chapter 10: Diabetic ketoacidosis. Pediatric Diabetes, 2009;10:118-133.
- International Diabetes Federation. IDF Consensus on Type 2 Diabetes Prevention21. http://www.idf.org/idf-consensus-type-2-diabetes-prevention adresinden 08/08/2011 tarihinde erişilmiştir.
- Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care. 2002; 25:1551–1556.
- Satman İ. Türkiye Diyabet Epidemiyoloji (TURDEP II) Çalışması Genel Sonuçları (20 yaş üstü). 32. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, TURDEP Paneli, 13-17 Ekim, Antalya, Kongre Kitabı. 2010.
- Abduelkarem AR, Sharif SI, Hammrouni AM, Aldouibi SS, Albraiki WM, El-Shareif HJ. Risk calculation of developing type 2 diabetes in Libyan adults. Practical Diabetes International. 2009;26(4):148-151.
- Bergmann A, Li J, Wang L, Schulze J, Bornstein SR, Schwarz PE. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population, Horm Metab Res. 2007;39:677–682.
- Lindstrom J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, Handke U et al. Take action to prevent diabetes – the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res. 2010;42 (1):37–55.
- Makrilakis K, Liatis S, Grammatikou S, Perrea D, Katsilambros N. Education and psychological aspects implementation and effectiveness of the first community life style intervention programme to prevent type 2 diabetes in Greece. The DE-PLAN study. Diabetic Medicine 2010;27: 459-465.
- Paulweber B, Valensi P, Lindsröm J, Lalic NM, Greaves CJ, Mckee M, et al, for the Writing Group, on behalf of the IMAGE Study Group. A European Evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010;42(1):3-36.
- Saaristo T, Moilanen L, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care. Diabetes Care 2010;33(10):2146-2151.
- The DPP Study Group. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. Diabetes Care 2000; 23(11):1619-29.
- Lin JW, Chang YC, Li HY, Chien YF, Wu MY, Tsai RY et al. Cross-sectional validation of diabetes risk scores for predicting diabetes, metabolic syndrome, and chronic kidney disease in Taiwanese. Diabetes Care 2009;32; 2294–2296.
- Makrilakis K, Liatis S, Grammatikou S, Perrea D, Stathi C, Tsiligros P, Katsilambros N. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes & Metabolism 2011; 37 (2): 144-151.
- Saaristo T, Peltonen M, Lindstrom J, Saarikoski L, Sundvall J, Eriksson JG et al. Cross-sectional evaluation of the Finnish diabetes risk score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res 2005; 2:67–72.
- Schwarz PEH, Li J, Reimann M, Schutte AE, Bergmann A, Hanefeld M, et al. The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism 2009;94 (3):920-926.
- Özbay D, Kırkpınar ED, Çöllü M, Baydaş Ş, Usta HH, Turhan A, et al. The relation between diabetes mellitus risk determined by findrisc scores and nutritional habits in Gülsuyu and Esenkent: A cross sectional screening study 2011. Acibadem University School of Medicine Student Research Congress, May 23-24, p. 32.
- Witte DR, Shipley MJ, Marmot MG, Brunner EJ. Performance of existing risk scores in screening for undiagnosed diabetes: an external validation study. Diabet Med 2010;27: 46-53.
- Absetz P, Oldenburg B, Hankonen N, Valve R, Heinonen H, Nissinen A, et al. Type 2 diabetes prevention in the real world: three-year results of the GOAL lifestyle implementation trial. Diabetes Care 2009;32(8):1418-1420.
- Balkau B, Lange C, Fezeu L, Tichet J, Lauzon-Guillain B, Czernichow S, et al. Predicting diabetes: clinical, biological, and genetic approaches: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).Diabetes Care 2008; 31(10): 2056-61.
- Schwarz PE, Lindstrom J, Kissimova-Scarbeck K, Szybinski Z, Barengo NC, Peltonen M et al. The European perspective of type 2 diabetes prevention: diabetes in Europe– prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project, Exp Clin Endocrinol Diabetes 2008;116:167-172.
- Schwarz PE, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice, Horm Metab Res 2009;41:86-97.
- Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E et al. Screening for type 2 diabetes: literature review and economic modelling, Health Technol Assess 2007; 11:1-125.
- Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diabetes Care, 2003;26:881-885.
- Holman RR, Paul SK, Bethel MA, Neil HAW, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359: 1565-1576.
- International Diabetes Federation. Studies. http://www.idf.org/studies adresinden 08/08/2011 tarihinde erişilmiştir.
